| Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects Y Ben-Shlomo, M Spears, C Boustred, M May, SG Anderson, EJ Benjamin, ... Journal of the American College of Cardiology 63 (7), 636-646, 2014 | 2028 | 2014 |
| Severe hypoglycemia and risks of vascular events and death S Zoungas, A Patel, J Chalmers, BE De Galan, Q Li, L Billot, M Woodward, ... New England Journal of Medicine 363 (15), 1410-1418, 2010 | 1785 | 2010 |
| Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ... Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009 | 1150 | 2009 |
| Diabetic kidney disease MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ... Nature reviews Disease primers 1 (1), 1-20, 2015 | 950 | 2015 |
| Diabetes and hypertension: a position statement by the American Diabetes Association IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, PM Muntner, ... Diabetes care 40 (9), 1273-1284, 2017 | 857 | 2017 |
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 834 | 2014 |
| Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the … International Hypoglycaemia Study Group s. heller@ sheffield. ac. uk Diabetologia 60 (1), 3-6, 2017 | 735 | 2017 |
| KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease IH de Boer, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 98 (4), S1-S115, 2020 | 624 | 2020 |
| Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials HJL Heerspink, T Ninomiya, S Zoungas, D de Zeeuw, DE Grobbee, ... The Lancet 373 (9668), 1009-1015, 2009 | 555 | 2009 |
| Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, ... Diabetologia 57, 2465-2474, 2014 | 553 | 2014 |
| Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials S Zoungas, H Arima, HC Gerstein, RR Holman, M Woodward, P Reaven, ... The lancet Diabetes & endocrinology 5 (6), 431-437, 2017 | 490 | 2017 |
| Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds S Zoungas, J Chalmers, T Ninomiya, Q Li, ME Cooper, S Colagiuri, ... Diabetologia 55, 636-643, 2012 | 437 | 2012 |
| Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management SA Amiel, P Aschner, B Childs, PE Cryer, BE de Galan, BM Frier, ... The lancet Diabetes & endocrinology 7 (5), 385-396, 2019 | 424 | 2019 |
| Intensive glucose control improves kidney outcomes in patients with type 2 diabetes V Perkovic, HL Heerspink, J Chalmers, M Woodward, M Jun, Q Li, ... Kidney international 83 (3), 517-523, 2013 | 403 | 2013 |
| Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from … S Zoungas, BE De Galan, T Ninomiya, D Grobbee, P Hamet, S Heller, ... Diabetes care 32 (11), 2068-2074, 2009 | 391 | 2009 |
| Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial Y Hirakawa, H Arima, S Zoungas, T Ninomiya, M Cooper, P Hamet, ... Diabetes care 37 (8), 2359-2365, 2014 | 384 | 2014 |
| The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference MG Shlipak, SL Tummalapalli, LE Boulware, ME Grams, JH Ix, V Jha, ... Kidney international 99 (1), 34-47, 2021 | 350 | 2021 |
| Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial S Zoungas, BP McGrath, P Branley, PG Kerr, C Muske, R Wolfe, ... Journal of the American College of Cardiology 47 (6), 1108-1116, 2006 | 314 | 2006 |
| Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence P Rossing, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 102 (5), 990-999, 2022 | 312* | 2022 |
| Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study AE Joham, HJ Teede, S Ranasinha, S Zoungas, J Boyle Journal of women's health 24 (4), 299-307, 2015 | 304 | 2015 |
